Copyright
©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 110797
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110797
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110797
Figure 1 Flowchart of the study.
MAFLD: Metabolic dysfunction-associated fatty liver disease; T2DM: Type 2 diabetes mellitus.
Figure 2 Prevalence of metabolic dysfunction-associated fatty liver disease by different age, sex, and body mass index.
A: The prevalence of MAFLD according to different age and gender; B: The prevalence of MAFLD according to different BMI and gender. BMI: Body mass index; MAFLD: Metabolic dysfunction-associated fatty liver disease.
- Citation: Lu NL, Lam HT, Vo TD. Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam. World J Gastroenterol 2025; 31(37): 110797
- URL: https://www.wjgnet.com/1007-9327/full/v31/i37/110797.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i37.110797